Get the Stockscreener App
12.90
3.45%
0.43
Lensar Inc stock is traded at $12.90, with a volume of 60,540.
It is up +3.45% in the last 24 hours and down -1.30% over the past month.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe and Asia.
See More
Previous Close:
$12.47
Open:
$12.54
24h Volume:
60,540
Relative Volume:
0.59
Market Cap:
$153.96M
Revenue:
$42.16M
Net Income/Loss:
$-14.38M
P/E Ratio:
-7.2067
EPS:
-1.79
Net Cash Flow:
$-9.90M
1W Performance:
+1.98%
1M Performance:
-1.30%
6M Performance:
+38.86%
1Y Performance:
+193.18%
1-Day Range:
$12.53
$12.96
1-Week Range:
$12.40
$12.96
52-Week Range:
$3.8001
$17.31
Lensar Inc Stock (LNSR) Company Profile
Name
Lensar Inc
Sector
Industry
Phone
888-536-7271
Address
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
12.90 | 152.17M | 42.16M | -14.38M | -9.90M | -1.79 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-24-21 | Initiated | SVB Leerink | Outperform |
Lensar Inc Stock (LNSR) Latest News
How hedge fund analytics apply to LENSAR Inc. stockEarnings Summary Report & Weekly High Potential Alerts - Newser
Quantitative breakdown of LENSAR Inc. recent moveWall Street Watch & Low Drawdown Investment Ideas - Newser
LENSAR Inc. Stock Lags Behind Sector BenchmarksTrade Performance Summary & Community Consensus Trade Alerts - mustnews.co.kr
Is LENSAR Inc. a candidate for recovery playDay Trade & Free Risk Controlled Daily Trade Plans - Newser
Using Ichimoku Cloud for LENSAR Inc. technicals2025 Price Momentum & Daily Market Momentum Tracking - Newser
Using economic indicators to assess LENSAR Inc. potentialWeekly Stock Analysis & AI Driven Stock Movement Reports - Newser
Will LENSAR Inc. outperform the market2025 Market Outlook & Safe Entry Momentum Stock Tips - Newser
What makes LENSAR Inc. stock price move sharply2025 Major Catalysts & Proven Capital Preservation Tips - beatles.ru
Identifying reversal signals in LENSAR Inc.2025 Momentum Check & Weekly Sector Rotation Insights - Newser
Combining machine learning predictions for LENSAR Inc.July 2025 Trends & High Conviction Trade Alerts - Newser
Is LENSAR Inc. meeting your algorithmic filter criteriaWeekly Market Report & Safe Capital Preservation Plans - Newser
Can swing trading help recover from LENSAR Inc. losses2025 Bull vs Bear & Consistent Return Investment Signals - Newser
SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors - GlobeNewswire Inc.
Published on: 2025-08-19 05:35:56 - Newser
Short interest data insights for LENSAR Inc.Weekly Investment Recap & Fast Gain Stock Trading Tips - Newser
Will LENSAR Inc. benefit from macro trendsEarnings Growth Summary & Reliable Price Breakout Signals - Newser
LENSAR Inc. stock trend forecastPortfolio Growth Summary & Daily Growth Stock Tips - Newser
Custom watchlist performance reports with LENSAR Inc.Weekly Market Report & Accurate Intraday Trading Signals - Newser
Market reaction to LENSAR Inc.’s recent newsMarket Performance Summary & AI Powered Market Trend Analysis - Newser
Lensar (LNSR) Q2 Revenue Rises 10% - AOL.com
LENSAR Inc. stock daily chart insightsPortfolio Return Report & Stock Portfolio Risk Management - Newser
What data driven models say about LENSAR Inc.’s futureTrade Ideas & Verified Entry Point Detection - Newser
What momentum shifts mean for LENSAR Inc.2025 Short Interest & Comprehensive Market Scan Insights - Newser
Published on: 2025-08-16 04:47:22 - Newser
Sector ETF performance correlation with LENSAR Inc.July 2025 Update & Low Drawdown Trading Techniques - Newser
How LENSAR Inc. stock performs during market volatilityGold Moves & Safe Capital Investment Plans - Newser
How to use Fibonacci retracement on LENSAR Inc.Fed Meeting & Daily Risk Controlled Trade Plans - Newser
Using Bollinger Bands to evaluate LENSAR Inc.2025 Performance Recap & Fast Entry High Yield Tips - Newser
Can LENSAR Inc. stock double in the next year2025 Valuation Update & Weekly Top Gainers Alerts - 선데이타임즈
Lensar Inc Stock (LNSR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lensar Inc Stock (LNSR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Winer Gary M | Director |
Aug 28 '24 |
Buy |
4.45 |
1,000 |
4,450 |
80,155 |
| Winer Gary M | Director |
Aug 26 '24 |
Buy |
4.58 |
802 |
3,673 |
78,655 |
| Winer Gary M | Director |
Aug 27 '24 |
Buy |
4.50 |
500 |
2,250 |
79,155 |
| Winer Gary M | Director |
Aug 22 '24 |
Buy |
4.30 |
2 |
9 |
77,853 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):